2001: Q&A with Renalytix Executive Chairman, Julian Baines

episode

The Vox Markets Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 9PM EDT 4 min · 23 Sep 2026 · NPR News Now

The forgotten nutrient every midlife woman needs – with Dr Craig Rose 41 min · 23 Sep 2026 · Age Better with Liz Earle

Bringing Kashmir’s lakes back to life 25 min · 23 Sep 2026 · The Documentary Podcast

Soup 56 min · 23 Sep 2026 · Three Bean Salad

AFL Record Editor Ash Browne | Grand Final edition on sale now! (23.09.26) 2 min · 23 Sep 2026 · Whateley

NPR News: 09-22-2026 8PM EDT 4 min · 23 Sep 2026 · NPR News Now

Report any issue

Source

Recorded11 Dec 2024

Publisheraudioboom.com ↗

Handlerec:10923175

Show notes

Watch on YouTube Renalytix #RENX, specialises in AI-powered diagnostics for kidney disease. Executive Chairman Julian Baines, in an interview with Vox Markets, highlighted the company's FDA-approved test, KidneyIntelX, which predicts end-stage renal disease risk in diabetic patients, improving outcomes and reducing healthcare costs.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in